vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Cloudflare, Inc. (NET). Click either name above to swap in a different company.
Cloudflare, Inc. is the larger business by last-quarter revenue ($614.5M vs $493.8M, roughly 1.2× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -2.0%, a 8.8% gap on every dollar of revenue. On growth, Cloudflare, Inc. posted the faster year-over-year revenue change (33.6% vs -1.7%). Over the past eight quarters, Cloudflare, Inc.'s revenue compounded faster (27.4% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Cloudflare, Inc. is an American technology company headquartered in San Francisco, California, that provides a range of internet services, including content delivery network (CDN) services, cloud cybersecurity, DDoS mitigation, and ICANN-accredited domain registration. The company's services act primarily as a reverse proxy between website visitors and a customer's hosting provider, improving performance and protecting against malicious traffic.
MD vs NET — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $614.5M |
| Net Profit | $33.7M | $-12.1M |
| Gross Margin | — | 73.6% |
| Operating Margin | 9.9% | -8.0% |
| Net Margin | 6.8% | -2.0% |
| Revenue YoY | -1.7% | 33.6% |
| Net Profit YoY | 10.5% | 6.0% |
| EPS (diluted) | $0.40 | $-0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $614.5M | ||
| Q3 25 | $492.9M | $562.0M | ||
| Q2 25 | $468.8M | $512.3M | ||
| Q1 25 | $458.4M | $479.1M | ||
| Q4 24 | $502.4M | $459.9M | ||
| Q3 24 | $511.2M | $430.1M | ||
| Q2 24 | $504.3M | $401.0M | ||
| Q1 24 | $495.1M | $378.6M |
| Q4 25 | $33.7M | $-12.1M | ||
| Q3 25 | $71.7M | $-1.3M | ||
| Q2 25 | $39.3M | $-50.4M | ||
| Q1 25 | $20.7M | $-38.5M | ||
| Q4 24 | $30.5M | $-12.8M | ||
| Q3 24 | $19.4M | $-15.3M | ||
| Q2 24 | $-153.0M | $-15.1M | ||
| Q1 24 | $4.0M | $-35.5M |
| Q4 25 | — | 73.6% | ||
| Q3 25 | — | 74.0% | ||
| Q2 25 | — | 74.9% | ||
| Q1 25 | — | 75.9% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 77.7% | ||
| Q2 24 | — | 77.8% | ||
| Q1 24 | — | 77.5% |
| Q4 25 | 9.9% | -8.0% | ||
| Q3 25 | 13.8% | -6.7% | ||
| Q2 25 | 12.8% | -13.1% | ||
| Q1 25 | 7.0% | -11.1% | ||
| Q4 24 | 7.8% | -7.5% | ||
| Q3 24 | 6.6% | -7.2% | ||
| Q2 24 | -31.3% | -8.7% | ||
| Q1 24 | 3.2% | -14.4% |
| Q4 25 | 6.8% | -2.0% | ||
| Q3 25 | 14.5% | -0.2% | ||
| Q2 25 | 8.4% | -9.8% | ||
| Q1 25 | 4.5% | -8.0% | ||
| Q4 24 | 6.1% | -2.8% | ||
| Q3 24 | 3.8% | -3.6% | ||
| Q2 24 | -30.3% | -3.8% | ||
| Q1 24 | 0.8% | -9.4% |
| Q4 25 | $0.40 | $-0.03 | ||
| Q3 25 | $0.84 | $0.00 | ||
| Q2 25 | $0.46 | $-0.15 | ||
| Q1 25 | $0.24 | $-0.11 | ||
| Q4 24 | $0.37 | $-0.05 | ||
| Q3 24 | $0.23 | $-0.04 | ||
| Q2 24 | $-1.84 | $-0.04 | ||
| Q1 24 | $0.05 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $943.5M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $1.5B |
| Total Assets | $2.2B | $6.0B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $943.5M | ||
| Q3 25 | $340.1M | $1.1B | ||
| Q2 25 | $224.7M | $1.5B | ||
| Q1 25 | $99.0M | $204.5M | ||
| Q4 24 | $229.9M | $147.7M | ||
| Q3 24 | $103.8M | $182.9M | ||
| Q2 24 | $19.4M | $157.0M | ||
| Q1 24 | $8.0M | $254.4M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $1.5B | ||
| Q3 25 | $890.7M | $1.3B | ||
| Q2 25 | $833.8M | $1.2B | ||
| Q1 25 | $789.2M | $1.4B | ||
| Q4 24 | $764.9M | $1.0B | ||
| Q3 24 | $732.5M | $973.1M | ||
| Q2 24 | $706.5M | $881.5M | ||
| Q1 24 | $856.2M | $797.2M |
| Q4 25 | $2.2B | $6.0B | ||
| Q3 25 | $2.2B | $5.8B | ||
| Q2 25 | $2.1B | $5.6B | ||
| Q1 25 | $2.0B | $3.7B | ||
| Q4 24 | $2.2B | $3.3B | ||
| Q3 24 | $2.1B | $3.1B | ||
| Q2 24 | $2.0B | $2.9B | ||
| Q1 24 | $2.2B | $2.8B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $190.4M |
| Free Cash FlowOCF − Capex | — | $105.2M |
| FCF MarginFCF / Revenue | — | 17.1% |
| Capex IntensityCapex / Revenue | — | 13.9% |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $287.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $190.4M | ||
| Q3 25 | $137.3M | $167.1M | ||
| Q2 25 | $137.2M | $99.8M | ||
| Q1 25 | $-117.5M | $145.8M | ||
| Q4 24 | $133.0M | $127.3M | ||
| Q3 24 | $91.8M | $104.7M | ||
| Q2 24 | $107.0M | $74.8M | ||
| Q1 24 | $-125.2M | $73.6M |
| Q4 25 | — | $105.2M | ||
| Q3 25 | — | $82.5M | ||
| Q2 25 | — | $39.9M | ||
| Q1 25 | — | $59.9M | ||
| Q4 24 | — | $54.2M | ||
| Q3 24 | — | $54.5M | ||
| Q2 24 | — | $45.2M | ||
| Q1 24 | — | $41.5M |
| Q4 25 | — | 17.1% | ||
| Q3 25 | — | 14.7% | ||
| Q2 25 | — | 7.8% | ||
| Q1 25 | — | 12.5% | ||
| Q4 24 | — | 11.8% | ||
| Q3 24 | — | 12.7% | ||
| Q2 24 | — | 11.3% | ||
| Q1 24 | — | 11.0% |
| Q4 25 | — | 13.9% | ||
| Q3 25 | — | 15.1% | ||
| Q2 25 | — | 11.7% | ||
| Q1 25 | — | 17.9% | ||
| Q4 24 | — | 15.9% | ||
| Q3 24 | — | 11.7% | ||
| Q2 24 | — | 7.4% | ||
| Q1 24 | — | 8.5% |
| Q4 25 | 3.39× | — | ||
| Q3 25 | 1.91× | — | ||
| Q2 25 | 3.49× | — | ||
| Q1 25 | -5.66× | — | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | 4.72× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -31.03× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
NET
| Sales Channel Directly To Consumer | $438.5M | 71% |
| Sales Channel Through Intermediary | $176.0M | 29% |
